Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02269 WUXI BIO
RTNominal down11.680 -0.040 (-0.341%)
Research Report

05/12/2023 14:25

{I-bank focus}Jefferies lowers WuXi Bio (02269) to HKD69

[ET Net News Agency, 5 December 2023] Jefferies lowered its target price for WuXi Bio
(02269) to HKD69 from HKD90 and maintained its "buy" rating.
The research house said the lower PT reflects possible volatility from sentiment on
geopolitical tension and on concerns over further/longer duration of current rate hike.
However, sentiment on abovementioned factors may change rapidly as they are macro related,
rather than company-specific. (RC)

Remark: Real time quote last updated: 21/06/2024 10:24
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.